Clinical Trial Update: A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety of inhaled XW001 in children with Respiratory syncytial virus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• XW001

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: RSV Infection | Phase 1, Phase 2 | Status: COMPLETED